We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 473 results
  1. Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review

    Background

    New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality of life.

    ...
    Chantal Depondt, Wim Van Paesschen, ... France Ferrière in Drugs - Real World Outcomes
    Article Open access 31 May 2021
  2. Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A

    Background

    Antiepileptic drugs, levetiracetam (LEV) and brivaracetam (BRV), bind to synaptic vesicle glycoprotein 2A (SV2A). In their anti-seizure...

    Mika Naganawa, Jean-Dominique Gallezot, ... Richard E. Carson in EJNMMI Research
    Article Open access 08 November 2022
  3. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis

    Introduction

    The aim was to evaluate the efficacy and tolerability of adjunctive brivaracetam (BRV) in adults with severely drug-resistant focal...

    Sang-Kun Lee, Kyoung Heo, ... Boeun Hur in Advances in Therapy
    Article 21 June 2021
  4. Effectiveness and Safety of Brivaracetam in Children

    Vykuntaraju K. Gowda, Balamurugan Nagarajan, ... Naveen Benakappa in Indian Journal of Pediatrics
    Article 12 February 2021
  5. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Background

    The association between antiseizure medications (ASMs) and suicidality remains controversial. Analyses of additional datasets are needed to...

    Emily E. Leppien, Bennett J. Doughty, ... Kenneth L. McCall in Clinical Drug Investigation
    Article 15 May 2023
  6. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study

    Background and Objective

    Status epilepticus in poststroke epilepsy is a challenging condition because of multiple vascular comorbidities and the...

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in CNS Drugs
    Article Open access 02 October 2023
  7. Brivaracetam

    Article 18 April 2020
  8. Die neuen anfallsunterdrückenden Medikamente für das Kindes- und Jugendalter

    Since the introduction of bromide into epilepsy treatment one third of all patients in childhood and adolescence are still resistant to treatment....

    Gerhard Kurlemann, Ruth Lehbrink, Henry Bosse in Monatsschrift Kinderheilkunde
    Article 15 February 2024
  9. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland

    Introduction

    There is an unmet need for well-tolerated antiepileptic drugs (AEDs) that effectively control focal onset seizures. This study aimed to...

    Saku Väätäinen, Erkki Soini, ... Reetta Kälviäinen in Advances in Therapy
    Article Open access 05 December 2019
  10. Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients

    Introduction

    Both levetiracetam (LEV) and brivaracetam (BRV) eliminate the electroencephalogram photoparoxysmal response (PPR) in the human phase IIa...

    Ronald C. Reed, William E. Rosenfeld, ... Dorothee G. A. Kasteleijn-Nolst Trenité in CNS Drugs
    Article Open access 19 September 2020
  11. Brivaracetam

    Article 30 November 2019
  12. Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review

    Background

    Brivaracetam is a high-affinity synaptic vesicle glycoprotein 2A ligand with high brain permeability and rapid onset of action. These...

    Francesco Brigo, Simona Lattanzi, ... Eugen Trinka in CNS Drugs
    Article 24 July 2019
  13. Neue Entwicklungen in der antikonvulsiven Therapie bei Menschen mit Intelligenzminderung

    The frequency of epilepsy is significantly higher in people with intellectual disability (PID) compared to other patients. Epilepsy in PID is often...

    Article 21 June 2022
  14. Brivaracetam

    Article 19 October 2019
Did you find what you were looking for? Share feedback.